Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Ovarian Neoplasms 25 Peritoneal Neoplasms 17 Fallopian Tube Neoplasms 11 Colorectal Neoplasms 8 Stomach Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Neoplasms 3 Hyperthermia 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Appendiceal Neoplasms 3 Adrenocortical Carcinoma 3 Sarcoma 2 Rhabdomyosarcoma 2 Recurrence 2 Mesothelioma, Malignant 2 Mesothelioma 2 Glioma 2 Glioblastoma 2 Desmoplastic Small Round Cell Tumor 2 Carcinoma 2 Brain Neoplasms 2 Adenoma, Islet Cell 2 Wilms Tumor 1 Retroperitoneal Neoplasms 1 Rectal Neoplasms 1 Pseudomyxoma Peritonei 1 Postoperative Complications 1 Pleural Effusion, Malignant 1 Peritoneal Cavity Cancer 1

Interventions

Oxaliplatin 2 Paclitaxel 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cytoreduction Surgical Procedures 1 Bupivacaine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Cancer × Cytoreduction Surgical Procedures × Clear all

NCT04122885 2019-10-10

IMMUNOPAC

University Hospital Tuebingen

Peritoneal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡